RECURRENT OVARIAN CANCER
Clinical trials for RECURRENT OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OVARIAN CANCER trials appear
Sign up with your email to follow new studies for RECURRENT OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Pronged attack on returning ovarian cancer begins testing
Disease control Not yet recruitingThis study is testing a new combination treatment for women whose ovarian cancer has returned but still responds to platinum-based chemotherapy. It first combines a new two-in-one immunotherapy drug with standard chemotherapy, then switches to a maintenance pill called olaparib. …
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
New therapy aims to ease the mental trauma of ovarian cancer
Symptom relief Not yet recruitingThis study is testing if a special talk therapy called CALM-TF can help reduce traumatic stress in women with advanced ovarian cancer. It will involve 300 women who will either receive 3-6 therapy sessions plus their usual cancer care, or just their usual care alone. Researchers …
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE3 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Feb 27, 2026 15:19 UTC